Tag: DSMB
Aelis Farma: positive opinion from the DSMB for the continuation of the phase 2b clinical study with AEF0117 in cannabis addiction – 07/05/2023 at 07:00
Aelis Farma receives the positive opinion of the DSMB for the continuation without change to the protocol of its phase 2b clinical study with AEF0117 in cannabis addiction The excellent…
Aelis Farma: received a positive opinion from the DSMB – 07/05/2023 at 07:41
(CercleFinance.com) – Aelis Farma has received the positive opinion of the Data Safety Monitoring Board (DSMB) for the continuation without change to the protocol of its phase 2b clinical study…
Lysogene Announces Positive DSMB Findings Recommending Study Continuation and Positive Biomarker Data in Phase 1 of Adaptive Gene Therapy Clinical Trial with LYS-GM101 for the Treatment of GM1 Gangliosidosis – 11/29/ 2022 at 6:00 PM
• Finalization of the treatment and follow-up at 6 months of the last patient recruited in the first phase of the adaptive clinical trial P1-GM-101 • The DSMB gave a…
Pherecydes Pharma announces the positive recommendation of the DSMB for the continuation of its phase II clinical study PhagoDAIR in osteoarticular infections on prostheses caused by Staphylococcus aureus – 2022-11-29 at 18:00
Nantes, November 29, 2022 – 6 p.m. CET – Pherecydes Pharma (FR0011651694 – ALPHE, PEA-PME eligible), a biotechnology company specializing in precision phage therapy intended to treat antibiotic-resistant and/or complicated…